XBiotech Inc. - stock earnings
XBIT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.6 million USD | ? USD |
| 2023Q3 | -7.4 million USD | ? USD |
| 2023Q2 | -8.7 million USD | ? USD |
| 2023Q1 | -3.8 million USD | ? USD |
| 2022Q4 | -3.2 million USD | 300000 USD |
| 2022Q3 | -12.7 million USD | 1.7 million USD |
| 2022Q2 | -11.6 million USD | 1.5 million USD |
| 2022Q1 | -5.4 million USD | 500000 USD |
| 2021Q4 | -6.5 million USD | 4.5 million USD |
| 2021Q3 | -3.3 million USD | 4.5 million USD |
| 2021Q2 | -5.1 million USD | 4.5 million USD |
| 2021Q1 | -2.6 million USD | 4.9 million USD |
| 2020Q4 | -1.8 million USD | 5.3 million USD |
| 2020Q3 | -2.5 million USD | 10.5 million USD |
| 2020Q2 | -6.8 million USD | 15.5 million USD |
| 2020Q1 | -14000 USD | 12.7 million USD |
| 2019Q4 | 686.5 million USD | ? USD |
| 2019Q3 | -6.2 million USD | ? USD |
| 2019Q2 | -5.9 million USD | ? USD |
| 2019Q1 | -5.9 million USD | ? USD |
| 2018Q4 | -6.1 million USD | ? USD |
| 2018Q3 | -5.1 million USD | ? USD |
| 2018Q2 | -5.9 million USD | ? USD |
| 2018Q1 | -4.1 million USD | ? USD |
| 2017Q4 | -7.2 million USD | ? USD |
| 2017Q3 | -6.2 million USD | ? USD |
| 2017Q2 | -9.1 million USD | ? USD |
| 2017Q1 | -10.6 million USD | ? USD |
| 2016Q4 | -16.4 million USD | ? USD |
| 2016Q3 | -12.5 million USD | ? USD |
| 2016Q2 | -13.6 million USD | ? USD |
| 2016Q1 | -10.3 million USD | ? USD |
| 2015Q4 | -11.9 million USD | ? USD |
| 2015Q3 | -10.7 million USD | ? USD |
| 2015Q2 | -6.7 million USD | ? USD |
| 2015Q1 | -8.1 million USD | ? USD |
| 2014Q4 | -5.9 million USD | ? USD |
| 2014Q3 | -7.0 million USD | ? USD |
| 2014Q2 | -3.9 million USD | ? USD |
| 2014Q1 | -4.5 million USD | ? USD |
| 2013Q4 | -2.5 million USD | ? USD |
XBIT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -24.6 million USD | 300000 USD |
| 2022 | -32.9 million USD | 4.0 million USD |
| 2021 | -17.4 million USD | 18.4 million USD |
| 2020 | -11.2 million USD | 44.0 million USD |
| 2019 | 668.6 million USD | 12.7 million USD |
| 2018 | -21.1 million USD | ? USD |
| 2017 | -33.2 million USD | ? USD |
| 2016 | -52.8 million USD | ? USD |
| 2015 | -37.5 million USD | ? USD |
| 2014 | -21.7 million USD | ? USD |
| 2013 | -9.9 million USD | ? USD |
| 2012 | -15.2 million USD | ? USD |
XBIT
Price: $8.16
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.81 USD
P/E Ratio: -7.22
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 35800
Ebitda: -47.9 millionMarket Capitalization: 250.0 million